283 related articles for article (PubMed ID: 21726204)
1. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
[TBL] [Abstract][Full Text] [Related]
2. KIR2DS3 is associated with protection against acute myeloid leukemia.
Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
[TBL] [Abstract][Full Text] [Related]
3. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
4. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
5. Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.
Beltrame LM; Sell AM; Moliterno RA; Clementino SL; Cardozo DM; Dalalio MM; Fonzar UJ; Visentainer JE
Tissue Antigens; 2013 Dec; 82(6):397-404. PubMed ID: 24498996
[TBL] [Abstract][Full Text] [Related]
6. Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.
García-León JA; Pinto-Medel MJ; García-Trujillo L; López-Gómez C; Oliver-Martos B; Prat-Arrojo I; Marín-Bañasco C; Suardíaz-García M; Maldonado-Sanchez R; Fernández-Fernández O; Leyva-Fernández L
Mol Immunol; 2011 Sep; 48(15-16):1896-902. PubMed ID: 21665278
[TBL] [Abstract][Full Text] [Related]
7. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.
Miyashita R; Tsuchiya N; Yabe T; Kobayashi S; Hashimoto H; Ozaki S; Tokunaga K
Arthritis Rheum; 2006 Mar; 54(3):992-7. PubMed ID: 16508981
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
[TBL] [Abstract][Full Text] [Related]
9. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
10. The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.
Wu GQ; Zhao YM; Lai XY; Luo Y; Tan YM; Shi JM; Li L; Zheng WY; Zhang J; Hu XR; Jin AY; He JS; Xie WZ; Ye XJ; Cai Z; Lin MF; Huang H
Bone Marrow Transplant; 2010 Oct; 45(10):1514-21. PubMed ID: 20173784
[TBL] [Abstract][Full Text] [Related]
11. KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.
van der Meer A; Schaap NP; Schattenberg AV; van Cranenbroek B; Tijssen HJ; Joosten I
Mol Immunol; 2008 Aug; 45(13):3631-8. PubMed ID: 18555529
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
13. KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.
Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fae I; Fischer GF; Kouba M; Pohlreich D; Kalhs P; Greinix HT
Bone Marrow Transplant; 2009 Jul; 44(2):97-103. PubMed ID: 19169284
[TBL] [Abstract][Full Text] [Related]
14. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
15. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.
Kröger N; Binder T; Zabelina T; Wolschke C; Schieder H; Renges H; Ayuk F; Dahlke J; Eiermann T; Zander A
Transplantation; 2006 Oct; 82(8):1024-30. PubMed ID: 17060849
[TBL] [Abstract][Full Text] [Related]
16. Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients.
Mousavi T; Shahsavar F; Farnia P; Tajik N; Soofi M
Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):189-94. PubMed ID: 21891825
[TBL] [Abstract][Full Text] [Related]
17. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
[TBL] [Abstract][Full Text] [Related]
18. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
[TBL] [Abstract][Full Text] [Related]
19. Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis.
Kitawaki J; Xu B; Ishihara H; Fukui M; Hasegawa G; Nakamura N; Mizuno S; Ohta M; Obayashi H; Honjo H
Am J Reprod Immunol; 2007 Dec; 58(6):481-6. PubMed ID: 17997746
[TBL] [Abstract][Full Text] [Related]
20. KIRs and their HLA ligands in remitting-relapsing multiple sclerosis.
Fusco C; Guerini FR; Nocera G; Ventrella G; Caputo D; Valentino MA; Agliardi C; Gallotti J; Morra VB; Florio C; Clerici M; Lombardi ML
J Neuroimmunol; 2010 Dec; 229(1-2):232-7. PubMed ID: 20826009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
